OpenURL Connection Search

Select item for more details and to access through your institution.

HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease.
Published in:
Brain: A Journal of Neurology, 2024, v. 147, n. 7, p. 2579, doi. 10.1093/brain/awae048
By:
- Yogeshwar, Selina M;
- Muñiz-Castrillo, Sergio;
- Sabater, Lidia;
- Peris-Sempere, Vicente;
- Mallajosyula, Vamsee;
- Luo, Guo;
- Yan, Han;
- Yu, Eric;
- Zhang, Jing;
- Lin, Ling;
- Bueno, Flavia Fagundes;
- Ji, Xuhuai;
- Picard, Géraldine;
- Rogemond, Véronique;
- Pinto, Anne Laurie;
- Heidbreder, Anna;
- Höftberger, Romana;
- Graus, Francesc;
- Dalmau, Josep;
- Santamaria, Joan
Publication type:
Article
Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines.
Published in:
NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0036-2
By:
- Sutton, Troy C.;
- Chakraborty, Saborni;
- Mallajosyula, Vamsee V. A.;
- Lamirande, Elaine W.;
- Ganti, Ketaki;
- Bock, Kevin W.;
- Moore, Ian N.;
- Varadarajan, Raghavan;
- Subbarao, Kanta
Publication type:
Article
Stalking influenza by vaccination with pre-fusion headless HA mini-stem.
Published in:
Scientific Reports, 2016, p. 22666, doi. 10.1038/srep22666
By:
- Valkenburg, Sophie A.;
- Mallajosyula, V. Vamsee Aditya;
- Li, Olive T. W.;
- Chin, Alex W. H.;
- Carnell, George;
- Temperton, Nigel;
- Varadarajan, Raghavan;
- Poon, Leo L. M.
Publication type:
Article
Isolation of a High Affinity Neutralizing Monoclonal Antibody against 2009 Pandemic H1N1 Virus That Binds at the 'Sa' Antigenic Site.
Published in:
PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0055516
By:
- Shembekar, Nachiket;
- Aditya Mallajosyula, Vamsee V.;
- Mishra, Arpita;
- Yeolekar, Leena;
- Dhere, Rajeev;
- Kapre, Subhash;
- Varadarajan, Raghavan;
- Gupta, Satish Kumar
Publication type:
Article
In vitro and in vivo characterization of designed immunogens derived from the CD-helix of the stem of influenza hemagglutinin.
Published in:
Proteins, 2013, v. 81, n. 10, p. 1759, doi. 10.1002/prot.24317
By:
- Mallajosyula, V. Vamsee Aditya;
- Citron, Michael;
- Lu, Xianghan;
- Meulen, Jan ter;
- Varadarajan, Raghavan;
- Liang, Xiaoping
Publication type:
Article
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-59600-4
By:
- Pothineni, Venkata Raveendra;
- Potula, Hari-Hara S. K.;
- Ambati, Aditya;
- Mallajosyula, Venkata Vamsee Aditya;
- Sridharan, Brindha;
- Inayathullah, Mohammed;
- Ahmed, Mohamed Sohail;
- Rajadas, Jayakumar
Publication type:
Article
CD8<sup>+</sup> T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19.
Published in:
Science Immunology, 2021, v. 6, n. 61, p. 1, doi. 10.1126/sciimmunol.abg5669
By:
- Mallajosyula, Vamsee;
- Ganjavi, Conner;
- Chakraborty, Saborni;
- McSween, Alana M.;
- Pavlovitch-Bedzyk, Ana Jimena;
- Wilhelmy, Julie;
- Nau, Allison;
- Manohar, Monali;
- Nadeau, Kari C.;
- Davis, Mark M.
Publication type:
Article
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.
Published in:
Science Translational Medicine, 2022, v. 14, n. 635, p. 1, doi. 10.1126/scitranslmed.abm7853
By:
- Chakraborty, Saborni;
- Gonzalez, Joseph C.;
- Sievers, Benjamin L.;
- Mallajosyula, Vamsee;
- Chakraborty, Srijoni;
- Dubey, Megha;
- Ashraf, Usama;
- Cheng, Bowie Yik-Ling;
- Kathale, Nimish;
- Tran, Kim Quyen Thi;
- Scallan, Courtney;
- Sinnott, Aanika;
- Cassidy, Arianna;
- Chen, Steven T.;
- Gelbart, Terri;
- Gao, Fei;
- Golan, Yarden;
- Ji, Xuhuai;
- Kim-Schulze, Seunghee;
- Prahl, Mary
Publication type:
Article
Humanized antibody neutralizing 2009 pandemic H1N1 virus.
Published in:
Biotechnology Journal, 2014, v. 9, n. 12, p. 1594, doi. 10.1002/biot.201400083
By:
- Shembekar, Nachiket;
- Mallajosyula, Vamsee V Aditya;
- Chaudhary, Piyush;
- Upadhyay, Vaibhav;
- Varadarajan, Raghavan;
- Gupta, Satish Kumar
Publication type:
Article
Influenza Hemagglutinin Head Domain Mimicry by Rational Design.
Published in:
Protein Journal, 2020, v. 39, n. 5, p. 434, doi. 10.1007/s10930-020-09930-z
By:
- Mallajosyula, V Vamsee Aditya;
- Swaroop, Shiv;
- Varadarajan, Raghavan
Publication type:
Article
Effective viral vector response to SARS–CoV‐2 booster vaccination in a patient with rheumatoid arthritis after initial ineffective response to messenger RNA vaccine.
Published in:
Arthritis & Rheumatology, 2022, v. 74, n. 3, p. 541, doi. 10.1002/art.41978
By:
- Baker, Matthew C.;
- Mallajosyula, Vamsee;
- Davis, Mark M.;
- Boyd, Scott D.;
- Nadeau, Kari C.;
- Robinson, William H.
Publication type:
Article
Hemagglutinin sequence conservation guided stem immunogen design from influenza A H3 subtype.
Published in:
Frontiers in Immunology, 2015, p. 1, doi. 10.3389/fimmu.2015.00329
By:
- V. Vamsee Aditya Mallajosyula;
- Citron, Michael;
- Ferrara, Francesca;
- Temperton, Nigel J.;
- Xiaoping Liang;
- Flynn, Jessica A.;
- Varadarajan, Raghavan
Publication type:
Article

Found: 12

HLA-DQB105 subtypes and not DRB110:01 mediates risk in anti-IgLON5 disease.

Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines.

Stalking influenza by vaccination with pre-fusion headless HA mini-stem.

Isolation of a High Affinity Neutralizing Monoclonal Antibody against 2009 Pandemic H1N1 Virus That Binds at the 'Sa' Antigenic Site.

In vitro and in vivo characterization of designed immunogens derived from the CD-helix of the stem of influenza hemagglutinin.

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.

CD8<sup>+</sup> T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19.

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.

Humanized antibody neutralizing 2009 pandemic H1N1 virus.

Influenza Hemagglutinin Head Domain Mimicry by Rational Design.

Effective viral vector response to SARS–CoV‐2 booster vaccination in a patient with rheumatoid arthritis after initial ineffective response to messenger RNA vaccine.

Hemagglutinin sequence conservation guided stem immunogen design from influenza A H3 subtype.